Biogen agrees to pay $900 million in largest FCA Settlement Ever Secured without Government’s Intervention
FDA Law
OCTOBER 3, 2022
district court of Massachusetts by former employee and whistleblower Michael Bawduniak in April 2012 as a qui tam action. The government also suspects violative conduct if the speakers, attendees, or consultants are selected based on the volume of their past prescriptions of the company’s products or their expected future prescriptions.
105 
Let's personalize your content